CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

The development of biomarkers to predict the progression of Parkinson’s disease (PD) from its earliest stage through its heterogeneous course is critical for research and therapeutic development. The Parkinson’s Progression Markers Initiative (PPMI) study is an ongoing international multicenter, pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Neuropathol
Main Authors: Kang, Ju-Hee, Mollenhauer, Brit, Coffey, Christopher S., Toledo, Jon B., Weintraub, Daniel, Galasko, Douglas R., Irwin, David J., Van Deerlin, Vivianna, Chen-Plotkin, Alice S., Caspell-Garcia, Chelsea, Waligórska, Teresa, Taylor, Peggy, Shah, Nirali, Pan, Sarah, Zero, Pawel, Frasier, Mark, Marek, Kenneth, Kieburtz, Karl, Jennings, Danna, Tanner, Caroline M., Simuni, Tanya, Singleton, Andrew, Toga, Arthur W., Chowdhury, Sohini, Trojanowski, John Q., Shaw, Leslie M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031365/
https://ncbi.nlm.nih.gov/pubmed/27021906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-016-1552-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados